BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19592243)

  • 1. Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.
    Lucas MC; Carter DS; Cai HY; Lee EK; Schoenfeld RC; Steiner S; Villa M; Weikert RJ; Iyer PS
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4630-3. PubMed ID: 19592243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.
    Pontillo J; Wu D; Ching B; Hudson S; Genicot MJ; Gao Y; Ewing T; Fleck BA; Gogas K; Aparicio A; Wang H; Wen J; Wade WS
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6151-5. PubMed ID: 18954981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
    Yeung JH; Or PM
    Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors.
    Moody DE; Liu F; Fang WB
    J Anal Toxicol; 2013 Oct; 37(8):476-85. PubMed ID: 23857299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine.
    Beulz-Riché D; Grudé P; Puozzo C; Sautel F; Filaquier C; Riché C; Ratanasavanh D
    Fundam Clin Pharmacol; 2005 Oct; 19(5):545-53. PubMed ID: 16176333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.
    He M; Jiang J; Qiu F; Liu S; Peng P; Gao C; Miao P
    Food Chem Toxicol; 2013 Jul; 57():262-5. PubMed ID: 23583485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors-Part 2.
    Yukawa T; Fujimori I; Kamei T; Nakada Y; Sakauchi N; Yamada M; Ohba Y; Ueno H; Takiguchi M; Kuno M; Kamo I; Nakagawa H; Fujioka Y; Igari T; Ishichi Y; Tsukamoto T
    Bioorg Med Chem; 2016 Jul; 24(14):3207-17. PubMed ID: 27255177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
    Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
    J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
    Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
    Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity, antioxidant activity and an effect on CYP3A4 and CYP2D6 of Mutellina purpurea L. extracts.
    Sieniawska E; Baj T; Dudka J; Gieroba R; Swiatek L; Rajtar B; Glowniak K; Polz-Dacewicz M
    Food Chem Toxicol; 2013 Feb; 52():188-92. PubMed ID: 23182739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.
    Hudson S; Kiankarimi M; Eccles W; Mostofi YS; Genicot MJ; Dwight W; Fleck BA; Gogas K; Wade WS
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4495-8. PubMed ID: 18667309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of immobilized enzyme reactors based on human recombinant cytochrome P450 enzymes for phase I drug metabolism studies.
    Nicoli R; Bartolini M; Rudaz S; Andrisano V; Veuthey JL
    J Chromatogr A; 2008 Oct; 1206(1):2-10. PubMed ID: 18556005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of the drug-drug interaction potential of catabolites of antibody-maytansinoid conjugates.
    Davis JA; Rock DA; Wienkers LC; Pearson JT
    Drug Metab Dispos; 2012 Oct; 40(10):1927-34. PubMed ID: 22752008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CYP3A4, but not of CYP2D6, promotes hypoxic response and cell growth of Hep3B cells.
    Oguro A; Sakamoto K; Funae Y; Imaoka S
    Drug Metab Pharmacokinet; 2011; 26(4):407-15. PubMed ID: 21566342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome b5 is a major determinant of human cytochrome P450 CYP2D6 and CYP3A4 activity in vivo.
    Henderson CJ; McLaughlin LA; Scheer N; Stanley LA; Wolf CR
    Mol Pharmacol; 2015 Apr; 87(4):733-9. PubMed ID: 25657337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study.
    Spanakis M; Vizirianakis IS; Mironidou-Tzouveleki M; Niopas I
    Biomed Chromatogr; 2009 Nov; 23(11):1131-7. PubMed ID: 19444798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes.
    Savai J; Varghese A; Pandita N; Chintamaneni M
    Phytother Res; 2015 May; 29(5):785-90. PubMed ID: 25684704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans.
    Thörn HA; Lundahl A; Schrickx JA; Dickinson PA; Lennernäs H
    Eur J Pharm Sci; 2011 Jun; 43(3):89-98. PubMed ID: 21447389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.